This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Tuberculosis


  • New Understanding of TB Could Lead to Personalized Treatments
    A team from Trinity College Dublin and St. James's Hospital have made a breakthrough in terms of how our immune system responds to tuberculosis (TB), which opens up the possibility to design more effective vaccines and personalized therapies. Dr. Clíona Ní ...More
    February 17, 2016 Posted in News
  • Most Commonly Used TB Test Fails to Accurately Diagnose Pregnant, HIV-Positive Women
    New research finds that the most commonly used test for tuberculosis fails to accurately diagnose TB in up to 50 percent of pregnant women who are HIV positive. The research published early online in the American Thoracic Society’s American Journal of Respiratory and ...More
    January 25, 2016 Posted in News
  • Better Healthcare Could Reduce Crippling Personal Costs of TB Care in China
    Improved universal healthcare is urgently needed to lower catastrophic health expenditure (CHE) for low-income tuberculosis (TB) patients in China, according to a study published in the open access journal Infectious Diseases of Poverty. Expanding universal healthcare could ...More
    January 25, 2016 Posted in News
  • Scientists Take Steps to Make Weak TB Drugs Strong Again
    Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme ...More
    January 19, 2016 Posted in News
  • Expanded Regimens Associated With Improved Treatment Response in MDR-TB
    Treating multidrug-resistant tuberculosis (MDR-TB) with regimens that include a greater number of drugs may improve outcomes, and baseline drug susceptibility testing (DST) could identify drugs with the greatest likelihood of success, according to a paper published this ...More
    December 29, 2015 Posted in News
  • CDC to Play Key Role in National Multidrug-Resistant TB Plan
    On Dec. 23, 2015, the White House released the National Action Plan to Combat Multidrug-Resistant Tuberculosis (MDR-TB), which is a crucial step to address MDR-TB, a growing public health threat that reflects missed opportunities to find, cure and prevent TB. Despite ...More
    December 29, 2015 Posted in News
  • Researchers Devise an Inexpensive, Quick Tuberculosis Test for Developing Countries
    Tuberculosis (TB) is a highly infectious disease and a major global health problem, especially in countries with developing healthcare systems. Because there is no fast, easy way to detect TB, the deadly infection can spread quickly through communities. Now, a team reports ...More
    December 16, 2015 Posted in News
  • Mothers, Infants May Have Been Exposed to TB at Northern California Hospital
    More than 1,000 individuals may have been exposed to tuberculosis in November after a nurse at Santa Clara Valley Medical Center in San Jose, Calif. was diagnosed with the disease, hospital officials announced last week. Santa Clara Valley Medical Center says that when it ...More
    December 15, 2015 Posted in News
  • Surprising Diversity of TB Strains Found in Ethiopia
    Ethiopia is a hotspot for tuberculosis (TB) infection, ranking third among African countries and eighth in the world for TB burden according to the World Health Organization. But, say researchers who have analyzed the genomes of 66 TB strains and reported their findings in ...More
    December 10, 2015 Posted in News
  • World's First Child-Friendly TB Medicines in Correct Doses
    The World Health Organization (WHO) joined the TB Alliance and partners today to announce the availability of child-friendly tuberculosis (TB) medicines in the correct doses. The improved treatments are the first to meet the dosage guidelines set by the WHO in 2010. They ...More
    December 3, 2015 Posted in News